Iwao Sugitani

5.1k total citations · 1 hit paper
127 papers, 3.6k citations indexed

About

Iwao Sugitani is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Iwao Sugitani has authored 127 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Endocrinology, Diabetes and Metabolism, 62 papers in Surgery and 24 papers in Oncology. Recurrent topics in Iwao Sugitani's work include Thyroid Cancer Diagnosis and Treatment (90 papers), Thyroid and Parathyroid Surgery (42 papers) and Head and Neck Anomalies (18 papers). Iwao Sugitani is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (90 papers), Thyroid and Parathyroid Surgery (42 papers) and Head and Neck Anomalies (18 papers). Iwao Sugitani collaborates with scholars based in Japan, United States and India. Iwao Sugitani's co-authors include Yoshihide Fujimoto, Keiko Yamada, Kazuhisa Toda, Akio Yanagisawa, Noriko Yamamoto, N Kasai, Akira Miyauchi, Kazuyoshi Kawabata, Motoko IKENAGA and Aya Ebina and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Iwao Sugitani

113 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma

2020 248 citations Iwao Sugitani, Yasuhiro Ito et al. Thyroid profile →

Peers

Countries citing papers authored by Iwao Sugitani

Since Specialization

Citations

This map shows the geographic impact of Iwao Sugitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwao Sugitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwao Sugitani more than expected).

Fields of papers citing papers by Iwao Sugitani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwao Sugitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwao Sugitani. The network helps show where Iwao Sugitani may publish in the future.

Co-authorship network of co-authors of Iwao Sugitani

This figure shows the co-authorship network connecting the top 25 collaborators of Iwao Sugitani. A scholar is included among the top collaborators of Iwao Sugitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwao Sugitani. Iwao Sugitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery 2025 ·Endocrine Journal ·Iwao Sugitani, Naomi Kiyota, Yasuhiro Ito, Naoyoshi Onoda, (unknown), Kiyomi Horiuchi, Seigo Kinuya, Tetsuo Kondo, (unknown), Kiminori Sugino, Hisato Hara	5
2	A Case of Stevens–Johnson Syndrome Induced by Selpercatinib 2025 ·The Journal of Dermatology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Iwao Sugitani, Naoko Kanda, Hidehisa Saeki, Toshihiko Hoashi	0
3	Japanese general rules for the description of thyroid cancer (9th edition) established by the Japan Association of Endocrine Surgery and the Japanese Society of Thyroid Pathology 2024 ·Hiroshi Kamma, Yasuhiro Ito, Shinichi Suzuki, (unknown), Nobuyasu Suganuma, Seigo Kinuya, Morimasa Kitamura, Kiyomi Horiuchi, (unknown), Chisato Tomoda, Kaori Kameyama, (unknown), Ryuji Ohashi, (unknown), Tomohiro Chiba, Masahiro Nakashima, Mitsuyoshi Hirokawa, Iwao Sugitani	1
4	Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report 2024 ·Surgical Case Reports ·(unknown), Ryo Ito, Takeshi Abe, (unknown), (unknown), (unknown), (unknown), Tomoo Jikuzono, Iwao Sugitani	0
5	A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer 2024 ·Thyroid ·Makoto Tahara, Hiroshi Takami, Yasuhiro Ito, Takahiro Okamoto, Iwao Sugitani, Kiminori Sugino, Shunji Takahashi, Hiroshi Takeyama, Hidemitsu Tsutsui, Hisato Hara, Ayako Mitsuma, Hiroyuki Yamashita, Yasuo Ohashi, Tsuneo Imai	9
6	Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy 2024 ·Endocrine Related Cancer ·Marcia S. Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer‐Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H. Taylor, Zhuoying Wang, Lori J. Wirth, Francis P. Worden, John Bernard, (unknown), (unknown), Shiguang Liu, Martin Schlumberger	4
7	Long-Term outcomes of active surveillance for low-risk papillary thyroid carcinoma: is lifelong follow-up necessary? 2023 ·Endocrine Abstracts ·Iwao Sugitani, Tomoo Jikuzono, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuhisa Toda	1
8	Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI) 2022 ·Thyroid ·Marcia S. Brose, Johannes W. A. Smit, Chia‐Chi Lin, Masayuki Tori, Daniel W. Bowles, Francis P. Worden, (unknown), Shih‐Ming Huang, Hui‐Jen Tsai, Maria Alevizaki, Robin P. Peeters, Shunji Takahashi, (unknown), (unknown), (unknown), (unknown), Iwao Sugitani, Fabián Pitoia, Livia Lamartina	13
9	Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE) 2022 ·European Journal of Cancer ·Takuya Higashiyama, Kiminori Sugino, Hisato Hara, Ken‐ichi Ito, (unknown), Naoyoshi Onoda, Masayuki Tori, Hiroshi Katoh, Naomi Kiyota, Ichiro Ota, Nobuyasu Suganuma, Yatsuka Hibi, (unknown), Shunji Takahashi, Katsunari Yane, Tetsuya Ioji, Shinsuke Kojima, Hideaki Kaneda, Iwao Sugitani, Makoto Tahara	32
10	Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis 2020 ·BMC Research Notes ·Tomoo Jikuzono, Tomoko Ishikawa, Mitsuyoshi Hirokawa, Iwao Sugitani, Osamu Ishibashi	1
11	Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma 2020 ·Cancers ·Naoyoshi Onoda, Iwao Sugitani, Ken‐ichi Ito, Akifumi Suzuki, Takuya Higashiyama, Tatsuya Fukumori, Nobuyasu Suganuma, Katsuhiko Masudo, Hirotaka Nakayama, Atsuhiko Uno, Katsunari Yane, Seiichi Yoshimoto, Aya Ebina, (unknown), Shigeto Maeda, Manabu Iwadate, Shinichi Suzuki	27
12	Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma breakdown → 2020 ·Thyroid ·Iwao Sugitani, Yasuhiro Ito, Dai Takeuchi, Hirotaka Nakayama, Chie Masaki, Hisakazu Shindo, Masanori Teshima, Kazuhiko Horiguchi, Yusaku Yoshida, Toshiharu Kanai, Mitsuyoshi Hirokawa, Kiyomi Y. Hames, Isao Tabei, Akira Miyauchi	248
13	Factors Influencing the Chemo-Sensitivity of Weekly Paclitaxel for Anaplastic Thyroid Cancer: A Clinico-Pathologic Analysis of Cases Enrolled in a Clinical Trial 2019 ·Naoyoshi Onoda, Mitsuyoshi Hirokawa, (unknown), Atsuhiko Sakamoto, Kiminori Sugino, (unknown), Nobuyasu Suganuma, Shinichi Suzuki, Ken‐ichi Ito, Iwao Sugitani	1
14	Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan 2019 ·Thyroid ·Iwao Sugitani, Yasuhiro Ito, Akira Miyauchi, Tsuneo Imai, Shinichi Suzuki	52
15	Proteinase K treatment improves RNA recovery from thyroid cells fixed with liquid-based cytology solution 2018 ·BMC Research Notes ·Tomoo Jikuzono, (unknown), Tomoko Ishikawa, Mitsuyoshi Hirokawa, Iwao Sugitani, Takashi Inui, Osamu Ishibashi	5
16	Fine needle aspiration cytology of the papillary thyroid carcinoma with a solid component: A cytological and clinical correlation 2017 ·Diagnostic Cytopathology ·Ryuji Ohashi, (unknown), (unknown), (unknown), Takehito Igarashi, Iwao Sugitani, Zenya Naito	8
17	Interim baseline characteristics from RIFTOS MKI, a global non-interventional study assessing the use of multikinase inhibitors (MKIs) in the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC): A European subgroup analysis 2017 ·Annals of Oncology ·Johannes W. A. Smit, Marcia S. Brose, Fabián Pitoia, C-C. Lin, Iwao Sugitani, Maria Alevizaki, Yann Godbert, Javier Aller, Robin P. Peeters, Kalliopi Pazaitou‐Panayiotou, Laurence Leenhardt, Marc Fellous, Yoriko De Sanctis, Martin Schlumberger	3
18	Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma 2010 ·Thyroid ·Yorihisa Orita, Iwao Sugitani, Kazuhisa Toda, Jun Manabe, Yoshihide Fujimoto	58
19	A NOVEL DEFINITION OF EXTRATHYROIDAL INVASION FOR PATIENTS WITH PAPILLARY THYROID CARCINOMA 2006 ·Toukeibu Gan ·Iwao Sugitani, Kazuyoshi Kawabata	1
20	OUTCOMES OF CAROTID ARTERY RESECTION 2004 ·Toukeibu Gan ·Hiroyuki Yonekawa, Kazuyoshi Kawabata, (unknown), Takeshi Beppu, Kouki Miura, Seiichi Yoshimoto, Hiroki Mitani, Iwao Sugitani, Hirofumi Fukushima, Tohru Sasaki, (unknown), Yasuhiro Ebihara, Atsushi Kondo, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact